BioGaia 

€0.000000
0
+€0.00+0% 00:00 Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

17JulExpected
Next
0.09
0.43
0.76
1.09
Expected EPS
0.09441493425
Actual EPS
N/A

Financials

21.63%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
141.99MRevenue
30.72MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BGL.MU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

BioGaia AB (publ) is a global enterprise dedicated to the development, marketing, and sale of probiotic products, all backed by documented health benefits. The company organizes its activities into three primary divisions: Pediatrics, Adult Health, and 'Other'. Within the Pediatric segment, BioGaia provides items such as liquid drops, oral rehydration solutions, and gut health tablets, alongside supplying probiotic cultures for integration into infant formula. The Adult Health segment offers both digestive health tablets and oral hygiene lozenges, as well as providing cultures that are incorporated into dairy products by its licensees. The 'Other' segment focuses on delivering packaging solutions. BioGaia's product portfolio addresses a wide array of health conditions, including infantile colic and digestive problems in children, acute and antibiotic-associated diarrhea, gingivitis, periodontal disease, general wellness, Helicobacter pylori infections (the bacterium causing gastric ulcers), and low bone density. All of the company's products are sold under the BioGaia brand. Founded in 1990, BioGaia AB (publ) is headquartered in Stockholm, Sweden.
Show more...
CEO
Ms. Theresa P. Agnew
Employees
224
Country
Sweden
ISIN
SE0000470395

Listings

0 Comments

Share your thoughts

FAQ

What is BioGaia stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Muenchen exchange BioGaia stocks are traded under the ticker BGL.MU.
When is the next BioGaia earnings date?
BioGaia is going to release the next earnings report on July 17, 2026.
What is BioGaia revenue for the last year?
BioGaia revenue for the last year amounts to 141.99M EUR.
What is BioGaia net income for the last year?
BGL.MU net income for the last year is 30.72M EUR.
How many employees does BioGaia have?
As of July 09, 2026, the company has 224 employees.
In which sector is BioGaia located?
BioGaia operates in the Health & Wellness sector.
When did BioGaia complete a stock split?
BioGaia has not had any recent stock splits.
Where is BioGaia headquartered?
BioGaia is headquartered in Stockholm, Sweden.